Blackstone’s Diversified Play: Banking, Biotech, and London Offices Fuel Strategic Growth
Blackstone’s strategic triad—banking equity in Banamex, a $250M life‑sciences JV with Johnson & Johnson, and a 15% boost to its London office portfolio—showcases how the firm leverages emerging markets, biotech breakthroughs, and ESG‑driven real est…
4 minutes to read









